Evaxion presents preclinical data on AI-designed CMV vaccine

Evaxion presents preclinical data on CMV vaccine candidate

Evaxion presents preclinical data on CMV vaccine candidate

Moderna vs. Recursion: Which Cutting-Edge Pharma Stock Is a Better Buy in 2026?

Moderna expands beyond vaccines while Recursion bets on AI-driven drug discovery, each with distinct risks, partnerships, and financial profiles.

FDA Panel Backs Moderna mRNA Flu Shot 9-0, Setting Up August Approval Decision

The FDA's Vaccines and Related Biological Products Advisory Committee voted 9-0 on June 18 to recommend Moderna's mRNA flu vaccine for adults 50 and older, the first such endorsement in U.S. history. The agency must now decide by August 5 whether to approve what would be the first licensed mRNA-based seasonal influenza vaccine, even as the Trump administration has canceled 500 million in mRNA research funding.

American vaccines that transformed public health over 250 years: 'Outweighs harm'

From smallpox eradication to COVID vaccines, explore the most significant vaccine breakthroughs in the U.S. over 250 years of fighting disease.

Moderna CEO: Cautiously Optimistic on Flu Vaccine Approval

The FDA advisory committee recommended Moderna's flu vaccine for approval. Moderna CEO Stéphane Bancel tells Romaine Bostick and Katie Greifeld he is cautiously optimistic the approval will happen. (Source: Bloomberg)

Can Artificial Intelligence Predict The Next Pandemic?

Artificial intelligence could be used to predict the next pandemic. Here are the digital maps being used to track viral threats.

AI is the next major biodefense tech priority

Artificial intelligence is changing how biological threats can be created, detected, and countered. The post AI is the next major biodefense tech priority appeared first on Atlantic Council.

Australians scientists develop painless alternative to traditional vaccines

There is hope for a potentially painless alternative to vaccines, as Australian scientists help develop a dissolvable patch to substitute traditional injections.

Universal COVID Vaccine Clears First Human Trial as Researchers Caution It Is Still Years Away

An AI-designed universal COVID vaccine passed Phase 1 safety in 39 adults. Here's what the results actually show and why public availability is still years away.

New Poll Connects Social Media and Chatbots With Spread of Vaccine Misinformation

A recent survey suggests that using apps and artificial intelligence for health advice may be linked to vaccine distrust.

ASCEND showcase crowns KNUST neonatal device top innovation

A neonatal health device developed by students at the Kwame Nkrumah University of Science and Technology (KNUST) has won top prize at the British Council's ASCEND Lion’s Den investor showcase in Accra. The Automated Neonatal Exchange Transfusion System (ANET), led by Dr Prince Odame and developed by a KNUST student team, was selected as the standout innovation after pitching to a panel of investors and industry experts at the British Council Auditorium on Monday.

“Nature is the most computationally efficient system we know”: How Refiant used swarm optimization to build a 10-million-token AI model

While the household-name frontier models race forward with version numbers and context windows of at least a million tokens, a The post “Nature is the most computationally efficient system we know”: How Refiant used swarm optimization to build a 10-million-token AI model appeared first on The New Stack.

New Hope for Diagnosis of Chronic Infections; and Ancestral Health (Paleo) Survey

A few items have recently come to my attention that may be of interest to Perfect Health Diet readers. First, my friend Chris Keller on Facebook reports that a new startup, Aperiomics, is offering tests that are capable of identifying Read more » The post New Hope for Diagnosis of Chronic Infections; and Ancestral Health (Paleo) Survey appeared first on Perfect Health Diet.

UK begins trials of Ebola vaccine developed in just eight weeks

The UK medicines regulator has given approval for an experimental vaccine to be tested on healthy adults.

Paul Goldsmith seeks advice on protection of electoral systems from growing AI threat

The National Cyber Security Centre has warned the threat of artificial intelligence is real and immediate.

The CDC just sidelined these childhood vaccines. Here's what they prevent

The childhood vaccines that the CDC is dropping from the recommended scheduled have successfully beat back illness and death in children from rotavirus, hepatitis and other pathogens.

NASA tests AI medic for astronauts too far from Earth to call a doctor

Please state the nature of the medical emergency

Dengue vaccine shows ability to address infectious diseases: BPOM

The Food and Drug Monitoring Agency (BPOM) stated that the launch of an mRNA-based dengue vaccine prototype ...

Palantir: Accelerating AI Risks

Palantir: Accelerating AI Risks

Teknologi perubatan AI,robotik masih perlu latihan pakar profesional

PUTRAJAYA: Penggunaan teknologi perubatan moden termasuk kecerdasan buatan (AI) dan robotik perlu disertai latihan profesional serta pematuhan piawaian keselamatan bagi memastikan manfaatnya dapat dinikmati pesakit tanpa risiko penyalahgunaan. Master Akademi Perubatan Malaysia (AMM), Prof. Datuk Dr. Hanafiah Harunarashid berkata, kemajuan teknologi kesihatan ketika ini sememangnya mampu membantu meningkatkan kualiti rawatan dan ketepatan diagnosis, namun aspek ... Read more The post Teknologi perubatan AI,robotik masih perlu latihan pakar profesional appeared first on Utusan Malaysia.

Matica Bio, VaxDome partner on antiviral hybrid vaccine development

Matica Biotechnology, the US contract development and manufacturing organization subsidiary of CHA Biotech, has partnered with Texas-based VaxDome Inc. to jointly develop an antigen-agnostic antiviral vaccine aimed at protecting against a broad range of infectious diseases. The collaboration will focus on advancing VaxDome's hybrid antiviral vaccine candidates into clinical trials. Under the agreement, Matica Biotechnology will provide process development, analytical development and the producti

If a Lyme disease vaccine gets approved, how would it go over? We asked hunters

Drugmakers are working on a potential new shot to prevent the tick-borne illness. How might it fare in the era of vaccine skepticism?

Experimental Ebola trial begins in Congo as death toll tops 500

The WHO-sponsored trial will test Mapp Biopharmaceutical Inc.’s monoclonal antibody cocktail MBP134 and Gilead Sciences Inc.’s antiviral remdesivir

Does the WNBA Not Like Caitlin Clark?

The Indiana Fever star has been treated like a virus that the league’s antibodies seek to reject.

State Government expands FluMist nasal spray flu vaccination program to include children aged 12-17

After a successful rollout for younger children, the State Government is expanding the FluMist program, making the needle-free influenza vaccine available for children and teenagers aged 12-17.

The Pentagon Lost Its War Against Flu Shots in Less than Two Months

Flu shots are mandatory once again, less than two months after being made optional, following a major military base outbreak.

What Came After Covid Could Reshape Medicine

The RNA technology used widely during the pandemic is already being adapted to fight the flu, RSV -- and even for personalized cancer vaccines.

South African pharmaceutical firm develops potential Ebola treatment

Clinical trials of a molecule that has been found to stop the virus from replicating itself in human body, to get underway